Literature DB >> 12532047

A case of primary cutaneous histoplasmosis in a patient with diabetes and multi-infarct dementia.

Aleksandar L Krunic1, Henry Carag, Maria M Medenica, Allan L Lorincz.   

Abstract

We report a case of primary cutaneous histoplasmosis in a fifty-year-old African-American woman with diabetes and multi-infarct dementia. The patient developed fever and crusted, nodulo-ulcerative lesions of the skin after accidental superficial trauma to the forehead. The biopsy revealed suppurative granulomatous inflammation with intracellular and extracellular yeast-like cells with associated clear halo measuring 3-4 mm in size. Systemic involvement was not found. The lesions cleared after treatment with itraconazole 200 mg twice a day for 3 weeks. The medication was continued for a total period of 3 months, with no signs of recurrence after one-year of follow-up.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12532047     DOI: 10.1111/j.1346-8138.2002.tb00226.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  4 in total

1.  Primary cutaneous histoplasmosis developed in the penis of an immunocompetent patient.

Authors:  Mauricio Paixão; Hélio Amante Miot; João Avancini; Walter Belda Júnior
Journal:  An Bras Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.896

2.  Unusual case of cellulitis due to primary cutaneous histoplasmosis.

Authors:  Vishesh Paul; Michael S Kuhlenschmidt
Journal:  BMJ Case Rep       Date:  2018-12-14

3.  Primary Cutaneous Histoplasmosis Masquerading as Lepromatous Leprosy.

Authors:  Jenna Blah Bhattacharya; Poonam Rani; Radhika Aggarwal; Seema Kaushal
Journal:  J Clin Diagn Res       Date:  2017-01-01

4.  Cutaneous ulcer in an immunosuppressed patient with adult onset Still's disease: primary cutaneous histoplasmosis?

Authors:  Michelle Larissa Zini Lise; Ronaldo Nunes Godinho; Flávia Moojen Brollo; Henrique Luiz Staub
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.